112 related articles for article (PubMed ID: 8050912)
21. Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.
de Bree R; Roos JC; Quak JJ; den Hollander W; van den Brekel MW; van der Wal JE; Tobi H; Snow GB; van Dongen GA
J Nucl Med; 1994 May; 35(5):775-83. PubMed ID: 8176458
[TBL] [Abstract][Full Text] [Related]
22. [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].
Kiefer J; Baum RP; Knecht R; Hertel A; Niesen A; von Ilberg C; Hör G
HNO; 1994 Sep; 42(9):546-52. PubMed ID: 7989226
[TBL] [Abstract][Full Text] [Related]
23. [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area].
Adamietz IA; Schemmann F; Baum RP; Knecht R; Saran F; Mose S; Thilmann C; Hör G; Böttcher HD
Strahlenther Onkol; 1995 May; 171(5):278-83. PubMed ID: 7770783
[TBL] [Abstract][Full Text] [Related]
24. [Immunoscintigraphic detection of metastasis in malignant melanoma in the head and neck area].
Rosanowski F; Briele B; Walther EK
Laryngorhinootologie; 1994 Feb; 73(2):94-7. PubMed ID: 8161416
[TBL] [Abstract][Full Text] [Related]
25. The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy.
Han S; Jin G; Wang L; Li M; He C; Guo X; Zhu Q
J Immunol Res; 2014; 2014():268479. PubMed ID: 24818166
[TBL] [Abstract][Full Text] [Related]
26. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ
J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies in the diagnosis and treatment of the colorectal cancer.
Dziki A
Acta Chir Iugosl; 1998; 45(2 Suppl):35-6. PubMed ID: 10951784
[No Abstract] [Full Text] [Related]
29. How far have we come with solid (nonhematologic) tumor radioimmunotherapy?
Breitz HB
J Nucl Med; 2000 Dec; 41(12):2011-4. PubMed ID: 11138686
[No Abstract] [Full Text] [Related]
30. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis.
Knogler K; Grünberg J; Zimmermann K; Cohrs S; Honer M; Ametamey S; Altevogt P; Fogel M; Schubiger PA; Novak-Hofer I
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):603-11. PubMed ID: 17255283
[TBL] [Abstract][Full Text] [Related]
31. Immunoadsorption: an enhancement strategy for radioimmunotherapy.
DeNardo GL; Maddock SW; Sgouros G; Scheibe PO; DeNardo SJ
J Nucl Med; 1993 Jun; 34(6):1020-7. PubMed ID: 8509840
[No Abstract] [Full Text] [Related]
32. Radiolabeling of antibodies for therapy and diagnosis.
Baranowska-Kortylewicz J; Dalrymple GV; Quadri SM; Harrison KA
Methods Mol Biol; 1995; 51():423-39. PubMed ID: 7581715
[No Abstract] [Full Text] [Related]
33. Targeting of a head and neck squamous cell carcinoma xenograft model using the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker.
Cheng J; Persson M; Tolmachev V; Siavaev I; Orlova A; Kairemo K; Anniko M
Acta Otolaryngol; 2004 Nov; 124(9):1078-85. PubMed ID: 15513553
[TBL] [Abstract][Full Text] [Related]
34. [Perspectives of using antibodies in the diagnosis and therapy of cancer].
Pecking A
Pathol Biol (Paris); 1993 Jan; 41(1):37-8. PubMed ID: 8316462
[No Abstract] [Full Text] [Related]
35. [Monoclonal antibodies in the diagnosis and therapy of lung cancer].
Campobasso N; Dammacco F
Recenti Prog Med; 1991 Dec; 82(12):642-51. PubMed ID: 1667710
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.
van Dongen GA; Leverstein H; Roos JC; Quak JJ; van den Brekel MW; van Lingen A; Martens HJ; Castelijns JA; Visser GW; Meijer CJ
Cancer Res; 1992 May; 52(9):2569-74. PubMed ID: 1568225
[TBL] [Abstract][Full Text] [Related]
37. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
[TBL] [Abstract][Full Text] [Related]
38. Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities.
Wong ET
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7151s-7157s. PubMed ID: 16203815
[TBL] [Abstract][Full Text] [Related]
39. Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.
Cheng J; Ekberg T; Engström M; Nestor M; Jensen HJ; Tolmachev V; Anniko M
Laryngoscope; 2007 Jun; 117(6):1013-8. PubMed ID: 17440426
[TBL] [Abstract][Full Text] [Related]
40. Basic immunology of antibody targeted radiotherapy.
Wong JY
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S8-14. PubMed ID: 16979446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
